Recent advances in neoadjuvant therapy for breast cancer is a research paper published in Faculty Reviews (2021). On theSindex it has a DataRank of 0.995. It has been cited 19 times, with 18 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0.545
From 14 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 18 citers.
NCI NIH HHS
Grant: P30 CA077598
NCI NIH HHS
Grant: P01 CA210961
National Institutes of Health
Grant: 5P30CA077598-08
Cancer Center Support Grant P30 CA77598-06
National Institutes of Health
Grant: 1P01CA210961-01A1
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
FWCI
1.18
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals